These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 11347679)

  • 1. Quinolone-resistance mechanisms and in vitro susceptibility patterns among European isolates of Streptococcus mitis, Streptococcus sanguis, and Streptococcus pneumoniae.
    Schmitz FJ; Fisher A; Boos M; Mayer S; Milatovic D; Fluit AC
    Eur J Clin Microbiol Infect Dis; 2001 Mar; 20(3):219-22. PubMed ID: 11347679
    [No Abstract]   [Full Text] [Related]  

  • 2. In vitro exchange of fluoroquinolone resistance determinants between Streptococcus pneumoniae and viridans streptococci and genomic organization of the parE-parC region in S. mitis.
    Janoir C; Podglajen I; Kitzis MD; Poyart C; Gutmann L
    J Infect Dis; 1999 Aug; 180(2):555-8. PubMed ID: 10395882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro activity of gemifloxacin (SB-265805) compared to eleven other antimicrobial agents against streptococcal isolates, excluding Streptococcus pneumoniae.
    Kerawala M; Ambler JE; Lee PY; Drabu YJ
    Eur J Clin Microbiol Infect Dis; 2001 Apr; 20(4):271-5. PubMed ID: 11399019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative in vitro activity of moxifloxacin against Gram-positive clinical isolates.
    Hoogkamp-Korstanje JA; Roelofs-Willemse J
    J Antimicrob Chemother; 2000 Jan; 45(1):31-9. PubMed ID: 10629010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of gyrA and parC mutations and resistance levels among fluoroquinolone-resistant isolates and laboratory-derived mutants of oral streptococci.
    Kaneko A; Sasaki J; Shimadzu M; Kanayama A; Saika T; Kobayashi I
    J Antimicrob Chemother; 2000 Jun; 45(6):771-5. PubMed ID: 10837428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of susceptibility testing to detect fluoroquinolone resistance mechanisms in Streptococcus pneumoniae.
    Richardson DC; Bast D; McGeer A; Low DE
    Antimicrob Agents Chemother; 2001 Jun; 45(6):1911-4. PubMed ID: 11353652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluoroquinolone resistance among recent clinical isolates of Streptococcus pneumoniae.
    Barry AL; Brown SD; Fuchs PC
    J Antimicrob Chemother; 1999 Mar; 43(3):428-9. PubMed ID: 10223606
    [No Abstract]   [Full Text] [Related]  

  • 8. In vitro development of resistance to newer fluoroquinolones in Streptococcus pneumoniae isolates with reduced susceptibility to ciprofloxacin.
    Mayer S; Boos M; Köhrer K; Fluit AC; Schmitz FJ
    Eur J Clin Microbiol Infect Dis; 2001 Apr; 20(4):288-91. PubMed ID: 11399024
    [No Abstract]   [Full Text] [Related]  

  • 9. In vitro development of resistance to six quinolones in Streptococcus pneumoniae, Streptococcus pyogenes, and Staphylococcus aureus.
    Boos M; Mayer S; Fischer A; Köhrer K; Scheuring S; Heisig P; Verhoef J; Fluit AC; Schmitz FJ
    Antimicrob Agents Chemother; 2001 Mar; 45(3):938-42. PubMed ID: 11181385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [In vitro bactericidal effect of temafloxacin and tosufloxacin against streptococci].
    Aubert G; Pozzetto B; Dorche G
    Pathol Biol (Paris); 1991 Dec; 39(10):1002-5. PubMed ID: 1666667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluoroquinolone resistance in atypical pneumococci and oral streptococci: evidence of horizontal gene transfer of fluoroquinolone resistance determinants from Streptococcus pneumoniae.
    Ip M; Chau SS; Chi F; Tang J; Chan PK
    Antimicrob Agents Chemother; 2007 Aug; 51(8):2690-700. PubMed ID: 17548487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluoroquinolone resistance is a poor surrogate marker for type II topoisomerase mutations in clinical isolates of Streptococcus pneumoniae.
    Millichap JJ; Pestova E; Siddiqui F; Noskin GA; Peterson LR
    J Clin Microbiol; 2001 Jul; 39(7):2719-21. PubMed ID: 11427605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activities of fluoroquinolones against antibiotic-resistant blood culture isolates of viridans group streptococci from across Canada.
    de Azavedo JC; Trpeski L; Pong-Porter S; Matsumura S; Low DE
    Antimicrob Agents Chemother; 1999 Sep; 43(9):2299-301. PubMed ID: 10471583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determining the frequency of resistance of Streptococcus pneumoniae to ciprofloxacin, levofloxacin, trovafloxacin, grepafloxacin, and gemifloxacin.
    Evans ME
    Eur J Clin Microbiol Infect Dis; 2001 Dec; 20(12):883-5. PubMed ID: 11837640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efflux and target mutations as quinolone resistance mechanisms in clinical isolates of Streptococcus pneumoniae.
    Broskey J; Coleman K; Gwynn MN; McCloskey L; Traini C; Voelker L; Warren R
    J Antimicrob Chemother; 2000 Apr; 45 Suppl 1():95-9. PubMed ID: 10824039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of clinical Streptococcus pneumoniae strains from Germany with decreased susceptibility to fluoroquinolones.
    Reinert RR; Al-Lahham A; Lütticken R; Boos M; Schmitz FJ
    J Antimicrob Chemother; 2002 Jun; 49(6):1015-8. PubMed ID: 12039895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial activity of BMS 284756, a novel des-fluoro (6) quinolone and seven fluoroquinolones against Streptococcus pneumoniae.
    Saravolatz L; Manzor O; Pawlak J; Belian B
    Clin Microbiol Infect; 2001 Oct; 7(10):572-3. PubMed ID: 11683802
    [No Abstract]   [Full Text] [Related]  

  • 18. Induction of resistance of Streptococcus pneumoniae to quinolones in vitro.
    Lafredo SC; Foleno BD; Fu KP
    Chemotherapy; 1993; 39(1):36-9. PubMed ID: 8383031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluoroquinolone resistance in Streptococcus pneumoniae.
    Kuehnert MJ; Nolte FS; Perlino CA
    Ann Intern Med; 1999 Aug; 131(4):312-3. PubMed ID: 10454959
    [No Abstract]   [Full Text] [Related]  

  • 20. In vitro activity of gatifloxacin against Streptococcus pneumoniae isolates in Germany.
    Reinert RR; Al-Lahham A; Lemmen S; Lütticken R
    J Antimicrob Chemother; 2000 Nov; 46(5):854-6. PubMed ID: 11062219
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.